Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rabies single-visit pre-exposure vaccination boostability study
ACTRN12626000068369Phase 4Recruiting
- Sponsor
- The University of Queensland
- Start
- May 2026
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of rabies virus inactivated antigen, A in rabies (4 arms), sponsored by The University of Queensland. Primary endpoints: Seroconversion at Day 63 ± 7 and Safety following rabies pre-exposure prophylaxis. Started May 2026; status: recruiting.
02
Drugs
rabies virus inactivated antigen, A
03
Conditions
rabies
Beyond the preview
Go deeper on ACTRN12626000068369.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12626000068369.